Cognitive effects of intentional weight loss in elderly obese individuals with mild cognitive impairment

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 3, 2016, Pages 1104-1112

  Horie, Nidia Celeste ^a   Serrao, Valeria T ^a   Simon, Sharon Sanz ^a   Gascon, Maria Rita Polo ^a   Dos Santos, Alessandra Xavier ^a   Zambone, Maria Aquimara ^a   Del Bigio De Freitas, Marta Merenciana ^a   Cunha Neto, Edecio ^a   Marques, Emerson Leonildo ^a   Halpern, Alfredo ^a   De Melo, Maria Edna ^a   Mancini, Marcio C ^a   Cercato, Cintia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; LEPTIN;

AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; COGNITION; CONTROLLED STUDY; COUNSELING; EXECUTIVE FUNCTION; FAT INTAKE; FEMALE; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VERBAL FLUENCY; VERBAL MEMORY; WEIGHT REDUCTION; COMPLICATION; GERIATRIC ASSESSMENT; MEMORY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY; WEIGHT LOSS PROGRAM;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; COGNITION; COUNSELING; EXECUTIVE FUNCTION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; OBESITY; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84960847764     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2315     Document Type: Article

References (46)

1. World Health Organization and Alzheimer's Disease International. Dementia: A Public Health Priority. Geneva, Switzerland: World Health Organization; 2012. Available at http://www.who.int/mental-health/publications/dementia-report-2012/en/. Accessed January 23, 2015.
2. Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. 2014;312(23): 2551-2561.
3. Gorospe EC, Dave JK. The risk of dementia with increased body mass index. Age Ageing. 2007;36:23-29.
4. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005;330(7504): 136011.
5. Murphy T, Dias GP, Thuret S. Effects of diet on brain plasticity in animal and human studies: mind the gap. Neural Plast. 2014;2014: 563160.
6. Witte AV, Fobker M, Gellner R, Knecht S, Flöel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci USA. 2009;106(4):1255-1260.
7. Marques EL, Halpern A, Corrêa Mancini M, et al. Changes in neu-ropsychological tests and brain metabolism after bariatric surgery. J Clin Endocrinol Metab. 2014:99(11):E2347-E2352.
8. Power BD, Alfonso H, Flicker L, Hankey GJ, Yeap BB, Almeida OP. Body adiposity in later life and the incidence of dementia: the health in men study. PLoS One. 2011;6(3):e17902.
9. Murphy RA, Patel KV, Kritchevsky SB, et al. Health, Aging, and Body Composition Study. Weight change, body composition, and risk of mobility disability and mortality in older adults: a population-based cohort study. J Am Geriatr Soc. 2014;62(8):1476-1483.
10. Harrington M, Gibson S, Cottrell RC. A review and meta-analysis of the effect of weight loss on all-cause mortality risk. Nutr Res Rev. 2009;22(1):93-108.
11. Portet F, Ousset PJ, Visser PJ, et al. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry. 2006;77(6):714-718.
12. World Health Organization. Global recommendations on physical activity for health. 2010. Available at http://whqlibdoc.who.int/publications/2010/9789241599979-eng.pdf. Accessed January 1, 2011.
13. Amorim P. Mini international neuropsychiatric interview (MINI): validação de entrevista breve para diagnóstico de transtornos men-tais. Rev Bras Psiquiatr. 2000;22(3):106-115.
14. Nakano MM. Versão Brasileira da Short Physical Performance Bat-tery-SPPB: Adaptação Cultural e Estudo da Confiabilidade. Monografia (Mestrado). Campinas, Brazil: UNICAMP, 2007;181.
15. Santana RI. Avanutri Revolution 4.0 (software). Rio de Janeiro: Avanutri Nutrição Serviços e Informática ME; 2009.
16. Universidade de Campinas. Núcleo de Estudos e Pesquisas em Ali-mentação. Tabela Brasileira de Composição de Alimentos-TACO. 4th ed. Campinas, Brazil: UNICAMP; 2011.
17. Gebhardt SE, Thomas RG. Home and Garden Bulletin 72: Nutritive Value of Foods. Washington, DC: United States Department of Agriculture; 2002.
18. Matsudo SM, Araújo TL, Matsudo VKR, et al. Questionário Inter-nacional de Atividade Física (IPAQ): estudo de validade e reprodu-tibilidade no Brasil. Rev Bras Ativ Saude. 2001;10:5-18.
19. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: Psychological Corporation; 1997.
20. Diniz LFM, Cruz MF, Torres VM, Cosenza RM. O teste de apren-dizagem auditivo-verbaldeRey:normas para uma população brasil-eira. Rev Bras Neurol. 2000;36:79-83.
21. Weschler D. Weschler Memory Scale-Revised Manual. New York, NY: Psychological Corporation; 1987.
22. Spreen O, Strauss E. A Compendium of Neuropsychological Test-Administration, Norms and Commentary. 2nd ed. New York, NY: Oxford University Press; 1998.
23. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976;12:313-324.
24. Caramelli P, Carthery MT, Charchat-Fichman H, Porto CS, Nitrini R. Teste de fluência verbal no diagnóstico da doença de Alzheimer leve: notas de corte em função daescolaridade. Arq Neuropsiquiatr. 2003;61(suppl 2):S32.
25. Sanchez MA, Lourenço RA. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): cross-cultural adaptation for use in Brazil. Cad Saude Publica. 2009;25:1455-1465.
26. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
27. Memória CM, Yassuda MS, Nakano EY, Forlenza OV. Brief screening formild cognitive impairment: validationoftheBrazilian version oftheMontrealcognitive assessment. Int J Geriatr Psychiatry.2013; 28(1):34-40.
28. Bottino CMC, Almeida OP, Tamai S, Forlenza OV, Scalco MZ, Carvalho IAM. Entrevista Estruturada Para o Diagnóstico de Tr-anstornos Mentais em Idosos-CAMDEX-The Cambridge Examination for Mental Disorders of the Elderly. Brazilian version (translated and adaptedonbehalfofthe editors). Cambridge, United Kingdom: Cambridge University Press; 1999.
29. Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE, Alzheimer's Disease Neuroimaging Initiative. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Arch Gen Psychiatry. 2011;68(9):961-969.
30. Riley KP, Jicha GA, Davis D, et al. Prediction of preclinical Alzheimer's disease: longitudinal ratesofchangeincognition. J Alzheimers Dis. 2011;25(4):707-717.
31. Cserjési R, Luminet O, Poncelet AS, Lénárd L. Altered executive function in obesity. Exploration of the role of affective states on cognitive abilities. Appetite. 2009;52(2):535-539.
32. García-Casares N, Jorge RE, García-Arnés JA, et al. Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study. J Alzheimers Dis. 2014;42(4): 1337-1346.
33. Ewers M, Walsh C, Trojanowski JQ, et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging. 2012;33(7):1203-1214.
34. Siervo M, Nasti G, Stephan BC, et al. Effects of intentional weight loss on physical and cognitive function in middle-aged and older obese participants: a pilot study. J Am Coll Nutr. 2012;31(2): 79-86.
35. Maki PM. Critical window hypothesisof hormone therapy and cognition: a scientific update on clinical studies. Menopause. 2013; 20(6):695-709.
36. Prins ND, Scheltens P. Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future. Alzheimers Res Ther. 2013;5(6):56.
37. Villeneuve S, Brisson D, Marchant NL, Gaudet D. The potential applications of apolipoprotein E in personalized medicine. Front Aging Neurosci. 2014;6:154.
38. Risner ME, Saunders AM, Altman JF, et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 2006;6(4):246-254.
39. Salloway S, Sperling R, Fox NC, et al. Bapineuzumab 301 and 302 Clinical Trial Investigators. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med. 2014;370(4): 322-333.
40. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and done-pezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352(23):2379-2388.
41. Wakimoto P, Block G. Dietary intake, dietary patterns, and changes with age: an epidemiological perspective. J Gerontol A Biol Sci Med Sci. 2001;56:65-80.
42. Lieb W, Beiser AS, Vasan RS, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009;302(23):2565-2572.
43. Rajagopalan P, Toga AW, Jack CR, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative. Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. Neu-roreport. 2013;24(2):58-62.
44. Gisou M, Soheila R, Nasser N. Evaluation of the effect of intrahip-pocampal injection of leptin on spatial memory. Afr J Pharm Pharmacol. 2009;3(9):443-448.
45. Schrijnemaekers AM, deJager CA, Hogervorst E, Budge MM. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls. J Clin Exp Neuropsychol. 2006;28(3):438-455.
46. Villareal DT, Apovian CM, Kushner RF, Klein S, American Society forNutrition. NAASO, The Obesity Society. Obesityinolder adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am JClin Nutr. 2005; 82:923-934.